Optimizing the dynamic treatment regime of in-hospital warfarin anticoagulation in patients after surgical valve replacement using reinforcement learning

Author:

Zeng Juntong123ORCID,Shao Jianzhun4,Lin Shen1235,Zhang Hongchang4,Su Xiaoting123,Lian Xiaocong46,Zhao Yan12,Ji Xiangyang46,Zheng Zhe12357ORCID

Affiliation:

1. National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases , Beijing, People’s Republic of China

2. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases , Beijing, People’s Republic of China

3. Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing, People’s Republic of China

4. Department of Automation, Tsinghua University , Beijing, People’s Republic of China

5. Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases , Beijing, People’s Republic of China

6. Beijing National Research Center for Information Science and Technology (BNRist), Tsinghua University , Beijing, People’s Republic of China

7. National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Fuwai Central-China Hospital, Central-China Branch of National Center for Cardiovascular Diseases , Zhengzhou, People’s Republic of China

Abstract

Abstract Objective Warfarin anticoagulation management requires sequential decision-making to adjust dosages based on patients’ evolving states continuously. We aimed to leverage reinforcement learning (RL) to optimize the dynamic in-hospital warfarin dosing in patients after surgical valve replacement (SVR). Materials and Methods 10 408 SVR cases with warfarin dosage–response data were retrospectively collected to develop and test an RL algorithm that can continuously recommend daily warfarin doses based on patients’ evolving multidimensional states. The RL algorithm was compared with clinicians’ actual practice and other machine learning and clinical decision rule-based algorithms. The primary outcome was the ratio of patients without in-hospital INRs >3.0 and the INR at discharge within the target range (1.8–2.5) (excellent responders). The secondary outcomes were the safety responder ratio (no INRs >3.0) and the target responder ratio (the discharge INR within 1.8–2.5). Results In the test set (n = 1260), the excellent responder ratio under clinicians’ guidance was significantly lower than the RL algorithm: 41.6% versus 80.8% (relative risk [RR], 0.51; 95% confidence interval [CI], 0.48–0.55), also the safety responder ratio: 83.1% versus 99.5% (RR, 0.83; 95% CI, 0.81–0.86), and the target responder ratio: 49.7% versus 81.1% (RR, 0.61; 95% CI, 0.58–0.65). The RL algorithms performed significantly better than all the other algorithms. Compared with clinicians’ actual practice, the RL-optimized INR trajectory reached and maintained within the target range significantly faster and longer. Discussion RL could offer interactive, practical clinical decision support for sequential decision-making tasks and is potentially adaptable for varied clinical scenarios. Prospective validation is needed. Conclusion An RL algorithm significantly optimized the post-operation warfarin anticoagulation quality compared with clinicians’ actual practice, suggesting its potential for challenging sequential decision-making tasks.

Funder

Ministry of Science and Technology of People’s Republic of China

Beijing Municipal Science and Technology Commission

Capital’s Funds for Health Improvement and Research (CFH

National High Level Hospital Clinical Research Funding

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3